Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA–restricted, genetically unmodified allogeneic T cells. The ...

Club Med, the world leader in premium all-inclusive mountain and beach resorts, today announced the development of Club Med ...

All rights reserved. Harvard Business Publishing is an affiliate of Harvard Business School.